Stephanie Krebs

Insider Reports History

Location
Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie Krebs:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 120,000 14 Feb 2025 Direct

Insider Reports Filed by Stephanie Krebs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 14 Feb 2025 1 $0 4 Chief Business Officer 14 Feb 2025, 18:06
SNSE Sensei Biotherapeutics, Inc. 20 Dec 2024 1 $0 4 Chief Business Officer 23 Dec 2024, 16:15
SNSE Sensei Biotherapeutics, Inc. 01 Nov 2023 1 $0 4 Chief Business Officer 02 Nov 2023, 16:53
SNSE Sensei Biotherapeutics, Inc. 01 Nov 2023 0 $0 3 Chief Business Officer 02 Nov 2023, 16:50